Progress in the use of mesenchymal stromal cells for osteoarthritis treatment

Area of Science:

• Regenerative Medicine
• Cell Therapy
• Osteoarthritis Research

Background:

• Osteoarthritis (OA) is a prevalent chronic joint disease with significant unmet medical needs due to limited efficacy of current treatments.
• Cell therapy, particularly using mesenchymal stromal cells (MSCs), presents a promising new avenue for OA management.

Purpose of the Study:

• To review the literature on mesenchymal stromal cells (MSCs) for osteoarthritis (OA) treatment over the past five years.
• To evaluate the feasibility, safety, and efficacy of MSC-based therapies for OA.

Main Methods:

• Literature review of pre-clinical and clinical studies on MSCs in OA treatment.
• Analysis of signaling pathways (MAPK, Wnt, Notch) involved in MSC-mediated chondrogenesis.
• Assessment of immunoregulatory and paracrine effects of MSCs.

Main Results:

• MSC therapy has demonstrated feasibility, safety, and efficacy in pre-clinical and clinical studies for OA.
• Key signaling pathways like MAPK, Wnt, and Notch are implicated in MSC-driven cartilage repair.
• MSCs exhibit immunoregulatory and paracrine effects beneficial for tissue repair.
• Extracellular vesicles from MSCs are emerging as a potential OA treatment.

Conclusions:

• Mesenchymal stromal cell therapy offers a viable and effective approach for managing osteoarthritis.
• Further research into MSC mechanisms, including signaling pathways and extracellular vesicles, is warranted for optimizing OA treatment strategies.